Literature DB >> 8551221

CD16-mediated p21ras activation is associated with Shc and p36 tyrosine phosphorylation and their binding with Grb2 in human natural killer cells.

R Galandrini1, G Palmieri, M Piccoli, L Frati, A Santoni.   

Abstract

The Src homology (SH) 2/SH3 domain-containing protein Grb2 and the oncoprotein Shc have been implicated in a highly conserved mechanism that regulates p21ras activation. We investigated the involvement of these adaptor proteins in the signaling pathway induced by CD16 or interleukin (IL) 2R triggering in human natural killer (NK) cells. Both p46 and p52 forms of Shc were rapidly and transiently tyrosine phosphorylated upon CD16 or IL-2 stimulation with different kinetics. Shc immunoprecipitates from lysates of CD16- or IL-2-stimulated NK cells contained Grb2 and an unidentified 145-kD tyrosine phosphoprotein. Grb2 immunoprecipitates from anti-CD16-stimulated NK cells contained not only Shc, but also a 36-kD tyrosine phosphoprotein (p36). The interaction between Grb2 and Shc or p36 occurred via the Grb2SH2 domain as indicated by in vitro binding assays using a bacteriologically synthesized glutathione S-transferase-Grb2SH2 fusion protein. We also present evidence that p21ras is activated by CD16 and IL-2R cross-linking. Accumulation of guanosine triphosphate-bound Ras was detected within 1 minute and occurred with kinetics similar to inductive protein tyrosine phosphorylation and Grb2 association of Shc and p36 adaptor proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8551221      PMCID: PMC2192421          DOI: 10.1084/jem.183.1.179

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  53 in total

1.  An alternative to SH2 domains for binding tyrosine-phosphorylated proteins.

Authors:  W M Kavanaugh; L T Williams
Journal:  Science       Date:  1994-12-16       Impact factor: 47.728

2.  Multiple cytokines stimulate the binding of a common 145-kilodalton protein to Shc at the Grb2 recognition site of Shc.

Authors:  L Liu; J E Damen; R L Cutler; G Krystal
Journal:  Mol Cell Biol       Date:  1994-10       Impact factor: 4.272

3.  B cell antigen receptor cross-linking induces tyrosine phosphorylation and membrane translocation of a multimeric Shc complex that is augmented by CD19 co-ligation.

Authors:  A C Lankester; G M van Schijndel; P M Rood; A J Verhoeven; R A van Lier
Journal:  Eur J Immunol       Date:  1994-11       Impact factor: 5.532

4.  The CR2/CD19 complex on human B cells contains the src-family kinase Lyn.

Authors:  C J van Noesel; A C Lankester; G M van Schijndel; R A van Lier
Journal:  Int Immunol       Date:  1993-07       Impact factor: 4.823

5.  Interleukin-2-induced tyrosine phosphorylation of p52shc in T lymphocytes.

Authors:  L A Burns; L M Karnitz; S L Sutor; R T Abraham
Journal:  J Biol Chem       Date:  1993-08-25       Impact factor: 5.157

6.  Role of Shc in the activation of Ras in response to epidermal growth factor and nerve growth factor.

Authors:  T Basu; P H Warne; J Downward
Journal:  Oncogene       Date:  1994-12       Impact factor: 9.867

7.  Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases.

Authors:  F Borrego; J Peña; R Solana
Journal:  Eur J Immunol       Date:  1993-05       Impact factor: 5.532

8.  Involvement of Shc in insulin- and epidermal growth factor-induced activation of p21ras.

Authors:  G J Pronk; A M de Vries-Smits; L Buday; J Downward; J A Maassen; R H Medema; J L Bos
Journal:  Mol Cell Biol       Date:  1994-03       Impact factor: 4.272

9.  Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity.

Authors:  J D Bonnema; L M Karnitz; R A Schoon; R T Abraham; P J Leibson
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

10.  The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling.

Authors:  E Y Skolnik; C H Lee; A Batzer; L M Vicentini; M Zhou; R Daly; M J Myers; J M Backer; A Ullrich; M F White
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

View more
  10 in total

1.  Role of prolactin in the in vitro development of interleukin-2-driven anti-tumoural lymphokine-activated killer cells.

Authors:  L Matera; G Bellone; J J Lebren; P A Kelly; E L Hooghe Peters; P F Di Celle; R Foa; M Contarini; G Avanzi; V Asnaghi
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

2.  Identification of human NK cells that are deficient for signaling adaptor FcRγ and specialized for antibody-dependent immune functions.

Authors:  Ilwoong Hwang; Tianxiang Zhang; Jeannine M Scott; Ae Ra Kim; Taehyung Lee; Tejaswi Kakarla; Ahrom Kim; John B Sunwoo; Sungjin Kim
Journal:  Int Immunol       Date:  2012-09-07       Impact factor: 4.823

Review 3.  A tale of two TRAPs: LAT and LAB in the regulation of lymphocyte development, activation, and autoimmunity.

Authors:  Deirdre M Fuller; Minghua Zhu; Chih-Wen Ou-Yang; Sarah A Sullivan; Weiguo Zhang
Journal:  Immunol Res       Date:  2011-04       Impact factor: 2.829

Review 4.  Regulation of lymphocyte development and activation by the LAT family of adapter proteins.

Authors:  Deirdre M Fuller; Weiguo Zhang
Journal:  Immunol Rev       Date:  2009-11       Impact factor: 12.988

5.  TGF-beta utilizes SMAD3 to inhibit CD16-mediated IFN-gamma production and antibody-dependent cellular cytotoxicity in human NK cells.

Authors:  Rossana Trotta; Jessica Dal Col; Jianhua Yu; David Ciarlariello; Brittany Thomas; Xiaoli Zhang; Jeffrey Allard; Min Wei; Hsiaoyin Mao; John C Byrd; Danilo Perrotti; Michael A Caligiuri
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

6.  Analysis of the linker for activation of T cells and the linker for activation of B cells in natural killer cells reveals a novel signaling cassette, dual usage in ITAM signaling, and influence on development of the Ly49 repertoire.

Authors:  Gillian C Whittaker; Deborah N Burshtyn; Selinda J Orr; Laura Quigley; Deborah L Hodge; Véronique Pascal; Weiguo Zhang; Daniel W McVicar
Journal:  Blood       Date:  2008-07-21       Impact factor: 22.113

7.  Fc gamma R-dependent mitogen-activated protein kinase activation in leukocytes: a common signal transduction event necessary for expression of TNF-alpha and early activation genes.

Authors:  R Trotta; P Kanakaraj; B Perussia
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

8.  Molecular cloning of the cDNA encoding pp36, a tyrosine-phosphorylated adaptor protein selectively expressed by T cells and natural killer cells.

Authors:  J R Weber; S Orstavik; K M Torgersen; N C Danbolt; S F Berg; J C Ryan; K Taskén; J B Imboden; J T Vaage
Journal:  J Exp Med       Date:  1998-04-06       Impact factor: 14.307

9.  Killer cell inhibitory receptor recognition of human leukocyte antigen (HLA) class I blocks formation of a pp36/PLC-gamma signaling complex in human natural killer (NK) cells.

Authors:  N M Valiante; J H Phillips; L L Lanier; P Parham
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

Review 10.  NK Cell-Fc Receptors Advance Tumor Immunotherapy.

Authors:  Emilio Sanseviero
Journal:  J Clin Med       Date:  2019-10-12       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.